Intimation of appointment of Secretarial Auditor under Regulation 30of SEBI(LODR) Regulation 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Welcure Drugs & Pharmaceuticals Ltd approved the appointment of M/s. Vishakha Agrawal & Associates, Practicing Company Secretaries, as the Secretarial Auditor of the company on September 02, 2025. The appointment is for a period of 5 years, covering financial years 2025-26 to 2029-30, and is subject to shareholder approval at the upcoming Annual General Meeting. The firm, led by Vishakha Agrawal, has experience in company law, securities laws, and secretarial audits, and is not related to any directors of the company. This filing is made under Regulation 30 of the SEBI LODR Regulations, 2015.
This is a routine regulatory compliance filing and is not expected to have any material impact on the stock price or shareholder value. Appointment of a secretarial auditor is a mandatory requirement under the Companies Act and SEBI regulations.